ArticleCost effectiveness and resource allocation : C/E2026
Cost-effectiveness of a brief cognitive-behavioral outpatient rehabilitation program for patients with post-COVID-19 condition within a pragmatic randomized controlled trial.
Article in Cost effectiveness and resource allocation : C/E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05196451 (Short-time Behavioural Intervention in Post-Covid Syndrome), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Short-time Behavioural Intervention in Post-Covid Syndrome (SIPCOV): A Pragmatic Randomised Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-COVID-19 condition is an ongoing public health concern, and the lack of established treatments increases health care utilization. Recent evidence suggests that cognitive and behavioral approaches reduce symptoms and improve functional capabilities. This study reports the cost-effectiveness of a brief outpatient cognitive-behavioral rehabilitation program compared to care as usual in non-hospitalized patients with post-COVID-19 condition.
methodsAn economic evaluation based on a randomized clinical trial was conducted from a health care sector perspective. Health care utilization was charted using a self-developed questionnaire administered immediately after the intervention as well as 12 months after inclusion. Health-related quality of life was measured using the EQ-5D-5L inventory at inclusion and follow-ups and valued using the Norwegian tariff. We used multiple imputation with chained equations to impute missing data. To illustrate analysis of uncertainty, bootstrapping was performed. To account for correlation between costs and quality-adjusted life years (QALYs), we conducted seemingly unrelated regression. Costs and QALYs were summarized over the entire 12-month follow-up period.
resultsOver 12 months, analysis yielded an incremental QALY gain of 0.056 (95% CI: 0.024 to 0.077) and an overall cost reduction of NOK − 20,682 (95% CI: -47230 to -1614) per patient receiving the brief outpatient rehabilitation program compared to care as usual. A total of 100% of simulations indicated that the intervention was cost-effective.
conclusionA brief outpatient rehabilitation program based on a cognitive and behavioral approach was cost-effective compared to care as usual in non-hospitalized patients with post-COVID-19 condition. Further investigations of comparable clinical trials within other health care systems are warranted.
trial registrationClinicalTrials.gov Identifier: NCT05196451, 19th January 2022.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.